What the company does
SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis; host targeted treatment for viral infections such as respiratory infections, dengue virus, as well as polymyalgia rheumatica (PMR); and idiopathic membranous nephropathy. It is also developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB …
What the weekly tape is saying
SYNACT closed the latest completed week at 14.50 SEK. The 4-week return is 0.1% and the 12-week return is -14.1%. Trend Signal is inactive, Market Dynamics is -0.55. Setup signature: Risk-first tape with a 28/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 18.86 SEK
- Vs Trend Line
- -23.1%
- Fair Value
- 19.65 SEK
- Vs Fair Value
- -26.2%
- 52W High
- 25.30 SEK
- 52W Low
- 12.82 SEK
- Drawdown
- -42.7%
- Range Position
- 13.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 31
- 52W Active Breadth
- 59.6%
- Sector Scope
- SE Healthcare
- Sector Rank
- 20 of 158
- Sector Percentile
- 87.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 43 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 20 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.55
- 4W MD Change
- 55.9%
- Relative Strength
- -32.90
- 4W RS Change
- -0.3%
- Expectation
- Undecided
- Probability
- 48.19%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.8M
- 13W Average
- 1.5M
- 52W Average
- 957.9K
- Vs 13W
- 1.2x
- Vs 52W
- 1.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.6%
- 52W Volatility
- 8.6%
- Upside Weeks
- 22
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 7.7% / -5.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 944.1M
Opportunity signals
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 14.50 SEK | 7.6% | 18.86 SEK | 19.65 SEK | -0.55 | -32.90 | 1.8M | Off |
| 5 Jun 2026 | 13.48 SEK | -22.6% | 19.09 SEK | 20.04 SEK | -0.73 | -38.05 | 2.6M | Off |
| 29 May 2026 | 17.42 SEK | 24.4% | 19.37 SEK | 20.41 SEK | -0.81 | -21.17 | 3.5M | Off |
| 22 May 2026 | 14.00 SEK | -3.3% | 19.59 SEK | 20.76 SEK | -1.22 | -36.82 | 1.4M | Off |
| 15 May 2026 | 14.48 SEK | 3.9% | 19.87 SEK | 21.15 SEK | -1.24 | -32.81 | 1.1M | Off |
| 8 May 2026 | 13.94 SEK | -20.7% | 20.11 SEK | 21.52 SEK | -1.23 | -36.53 | 2.8M | Off |
| 1 May 2026 | 17.58 SEK | -3.7% | 20.48 SEK | 21.88 SEK | -1.32 | -20.28 | 588.1K | Off |
| 24 Apr 2026 | 18.26 SEK | 6.8% | 20.65 SEK | 22.26 SEK | -1.32 | -19.07 | 692.2K | Off |
| 17 Apr 2026 | 17.10 SEK | -4.5% | 20.74 SEK | 22.63 SEK | -1.25 | -26.60 | 1.0M | Off |
| 10 Apr 2026 | 17.90 SEK | -1.8% | 20.83 SEK | 22.98 SEK | -1.20 | -21.92 | 647.9K | Off |
| 3 Apr 2026 | 18.22 SEK | 1.3% | 20.86 SEK | 23.34 SEK | -1.09 | -17.28 | 584.3K | Off |
| 27 Mar 2026 | 17.98 SEK | 6.5% | 20.89 SEK | 23.72 SEK | -0.98 | -15.74 | 997.0K | Off |
| 20 Mar 2026 | 16.88 SEK | -3.7% | 20.88 SEK | 24.07 SEK | -1.04 | -20.92 | 1.3M | Off |
| 13 Mar 2026 | 17.52 SEK | -1.8% | 20.92 SEK | 24.39 SEK | -1.06 | -22.10 | 1.8M | Off |